61 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
CNMD CONMED Corporation $79.56 $2.24B Buy
Article Searches
NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall http://www.zacks.com/stock/news/356399/nuvasive-nuva-q4-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-356399 Feb 22, 2019 - NuVasive (NUVA) reports growth in revenues across all key operating segments in the fourth quarter of 2018.
Genomic Health (GHDX) Q4 Earnings Beat Estimates, Margins Up http://www.zacks.com/stock/news/355998/genomic-health-ghdx-q4-earnings-beat-estimates-margins-up?cid=CS-ZC-FT-355998 Feb 21, 2019 - Genomic Health's (GHDX) year-over-year rise in revenues, driven by a solid uptick in the United States and internationally, makes us optimistic about the stock.
CVS Health's (CVS) Q4 Earnings Top Estimates, Margins Up http://www.zacks.com/stock/news/355792/cvs-healths-cvs-q4-earnings-top-estimates-margins-up?cid=CS-ZC-FT-355792 Feb 20, 2019 - CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition holds immense promise.
Here's Why Investors Should Buy CONMED (CNMD) Stock Now http://www.zacks.com/stock/news/354506/heres-why-investors-should-buy-conmed-cnmd-stock-now?cid=CS-ZC-FT-354506 Feb 14, 2019 - CONMED's (CNMD) guidance for 2019 buoys optimism in the stock.
DaVita (DVA) Q4 Earnings Beat and Revenues Miss Estimates http://www.zacks.com/stock/news/354494/davita-dva-q4-earnings-beat-and-revenues-miss-estimates?cid=CS-ZC-FT-354494 Feb 14, 2019 - DaVita's (DVA) Q4 results gain from increasing dialysis services in and outside the United States.
STERIS (STE) Q3 Earnings In Line, Revenues Beat Estimates http://www.zacks.com/stock/news/353771/steris-ste-q3-earnings-in-line-revenues-beat-estimates?cid=CS-ZC-FT-353771 Feb 12, 2019 - STERIS (STE) continues to gain from strength in all business segments in Q3.
Omnicell (OMCL) Q4 Earnings Beat Estimates, Revenues Miss http://www.zacks.com/stock/news/353333/omnicell-omcl-q4-earnings-beat-estimates-revenues-miss?cid=CS-ZC-FT-353333 Feb 08, 2019 - Omnicell (OMCL) steadily benefits from product introductions, strategic alliances and digital conversions.
Cardinal Health (CAH) Beats on Q2 Earnings, Ups FY19 View http://www.zacks.com/stock/news/352865/cardinal-health-cah-beats-on-q2-earnings-ups-fy19-view?cid=CS-ZC-FT-352865 Feb 07, 2019 - Cardinal Health's (CAH) Q2 results benefit from strong sales in the Pharmaceutical segment. An upbeat guidance is indicative of brighter prospects.
Cerner (CERN) Q4 Earnings Meet Estimates, Revenues Miss http://www.zacks.com/stock/news/352406/cerner-cern-q4-earnings-meet-estimates-revenues-miss?cid=CS-ZC-FT-352406 Feb 06, 2019 - Cerner (CERN) gains from solid segmental revenues in fourth-quarter 2018. However, the company's 2019 guidance disappoints.
Omnicell Solid on Geographic Expansion Amid Stiff Competition http://www.zacks.com/stock/news/351754/omnicell-solid-on-geographic-expansion-amid-stiff-competition?cid=CS-ZC-FT-351754 Feb 04, 2019 - Omnicell (OMCL) gains from expanding into new markets. Stiff rivalry is a concern.

Pages: 1234567

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NXTM NxStage Medical, Inc. NASDAQ $28.33 $1.86B
AXGN AxoGen, Inc. NASDAQ $34.1 $1.31B
BABY Natus Medical Incorporated NASDAQ $33.675 $1.13B
VRAY ViewRay, Inc. NASDAQ $9.17 $860.65M
CUTR Cutera, Inc. NASDAQ $30.8 $426.17M
Sector: Health Care > Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus
DeepLinks for CONMED
CNMD - Google Finance https://www.google.com/finance?q=CNMD Industry related info and international coverage Summary News
CNMD - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=CNMD Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options